Literature DB >> 14508775

The effect of brain tumor angiogenesis on the in vivo relationship between the gradient-echo relaxation rate change (DeltaR2*) and contrast agent (MION) dose.

Arvind P Pathak1, Scott D Rand, Kathleen M Schmainda.   

Abstract

PURPOSE: To determine in vivo if the susceptibility calibration factor for gradient-echo imaging (k(G)), which characterizes the relationship between the tissue T2* relaxation rate change (DeltaR2*) and tissue contrast agent concentration, is independent of tissue type and condition; in addition, to assess the consequences of such an assumption on the use of relative cerebral blood volume (rCBV) measurements as a direct index of tumor angiogenesis.
MATERIALS AND METHODS: The DeltaR2* was measured as a function of monocrystalline iron oxide nanoparticles (MION) contrast agent dose in a rat brain tumor (9L gliosarcoma) model, the blood volume fraction independently measured, and k(G) calculated and compared for the normal gray matter, normal white matter, tumor, and contralateral brain.
RESULTS: The k(G) was found to be the same for gray and white matter (P = 0.53), but statistically different for tumor compared to contralateral brain (P = 0.005) with k(G(Tumor) ) < k(G(Brain) )
CONCLUSION: The gradient-echo calibration factor, k(G), is the same for brain gray and white matter, but not the same for brain and tumor tissue. This difference may be attributed to the grossly different vascular morphology of tumors, dueto tumor angiogenesis, compared to normal brain and/or possibly differing blood rheological factors such as hematocrit. Consequently, the sensitivity to blood volume differences between tumor and normal brain tissue may be lessened when using gradient-echo susceptibility contrast agent methods. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14508775     DOI: 10.1002/jmri.10371

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  21 in total

1.  How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.

Authors:  Adriana T Perles-Barbacaru; Boudewijn P J van der Sanden; Regine Farion; Hana Lahrech
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

2.  An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus.

Authors:  Ana C Pereira; Dan E Huddleston; Adam M Brickman; Alexander A Sosunov; Rene Hen; Guy M McKhann; Richard Sloan; Fred H Gage; Truman R Brown; Scott A Small
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-20       Impact factor: 11.205

3.  Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas.

Authors:  H W M van Laarhoven; G Gambarota; A Heerschap; J Lok; I Verhagen; A Corti; S Toma; C Gallo Stampino; A van der Kogel; C J A Punt
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

4.  A novel technique for modeling susceptibility-based contrast mechanisms for arbitrary microvascular geometries: the finite perturber method.

Authors:  Arvind P Pathak; B Douglas Ward; Kathleen M Schmainda
Journal:  Neuroimage       Date:  2008-01-29       Impact factor: 6.556

5.  Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters.

Authors:  C Chad Quarles; John C Gore; Lei Xu; Thomas E Yankeelov
Journal:  Magn Reson Imaging       Date:  2012-05-21       Impact factor: 2.546

6.  Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis.

Authors:  Kathleen M Schmainda; Scott D Rand; Allen M Joseph; Rebecca Lund; B Doug Ward; Arvind P Pathak; John L Ulmer; Michael A Badruddoja; Michael A Baddrudoja; Hendrikus G J Krouwer
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

7.  Noninvasive detection of temozolomide in brain tumor xenografts by magnetic resonance spectroscopy.

Authors:  Yoshinori Kato; David A Holm; Baasil Okollie; Dmitri Artemov
Journal:  Neuro Oncol       Date:  2009-10-20       Impact factor: 12.300

8.  Vascular phenotyping of brain tumors using magnetic resonance microscopy (μMRI).

Authors:  Eugene Kim; Jiangyang Zhang; Karen Hong; Nicole E Benoit; Arvind P Pathak
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-09       Impact factor: 6.200

9.  Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods.

Authors:  Barjor Gimi; Arvind P Pathak; Ellen Ackerstaff; Kristine Glunde; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2005-04-01       Impact factor: 10.961

Review 10.  Cerebral blood volume MRI with intravascular superparamagnetic iron oxide nanoparticles.

Authors:  Seong-Gi Kim; Noam Harel; Tao Jin; Tae Kim; Phil Lee; Fuqiang Zhao
Journal:  NMR Biomed       Date:  2012-12-04       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.